Effect of TRPV1 Channel Inhibitor on Physiological Parameters of ICR Mice under Chronic Stress
https://doi.org/10.33647/2074-5982-21-4-138-142
Abstract
Depression and anxiety disorders are among the most common psychiatric problems worldwide. The most important factor leading to the development of psychiatric disorders is chronic stress. TRPV1 channels in the central nervous system are known to be involved in neuronal plasticity and may be one of the links in the development of anxiety and depressive states. In our study, we used a selective blocker of this channel – APHC3, whose administration resulted in a reduction of anxiety and fear in animals in a model of acute stress. We have identified possible pathways for the development of psychiatric disorders when the body is exposed to chronic stress.
About the Authors
V. M. PavlovPuerto Rico
Vladimir M. Pavlov
142290, Moscow Region, Pushchino, Nauki Ave., 6
142290, Moscow Region, Pushchino, Nauki Ave., 3
A. Yu. Fedotova
Russian Federation
Anastasia Yu. Fedotov
142290, Moscow Region, Pushchino, Nauki Ave., 6
142290, Moscow Region, Pushchino, Nauki Ave., 3
Ya. A. Andreev
Russian Federation
Yaroslav A. Andreev
117997, Moscow, Miklukho-Maklaya Str., 16/10
I. A. Dyachenko
Russian Federation
Igor A. Dyachenko
142290, Moscow Region, Pushchino, Nauki Ave., 6
142290, Moscow Region, Pushchino, Nauki Ave., 3
References
1. Gladkikh I.N., et al. Ionnyj kanal TRPV1: strukturnye osobennosti, modulyatory aktivnosti, terapevticheskij potencial [TRPV1 ion channel: structural features, activity modulators, therapeutic potential]. Uspekhi biologicheskoj himii [Advances in biological Chemistry]. 2021;61:107– 154. (In Russian)].
2. Rukovodstvo po provedeniyu doklinicheskih issledovanij lekars-tvennyh sredstv [Guidelines for conducting preclinical studies of medicines]. Ed. by A.N. Mironov, et al. Moscow: Grif and K. Publ., 2012:213. (In Russian)].
3. Andreev Ya.A., et al. Polypeptide modulators of TRPV1 produce analgesia without hyperthermia. Marine drugs. 2013;11–12:5100–5115. DOI: 10.3390md11125100.
4. Esipov R.S., et al. Pilot production of the recombinant peptide toxin of Heteractis crispa as a potential analgesic by intein-mediated technology. Protein expression and purification. 2018;145:71–76. DOI: 10.1016/j.pep.2017.12.011.
5. Kozlov S.A., et al. New polypeptide components from the Heteractis crispa sea anemone with analgesic activity. Russian J. of Bioorganic Chemistry. 2009;35:711– 719. DOI: 10.1134/s1068162009060065.
6. Logashina Yu.A., et al. Anti-Inflammatory and Analgesic Effects of TRPV1 Polypeptide Modulator APHC3 in Models of Osteo- and Rheumatoid Arthritis. Marine drugs. 2021;19(1):39. DOI: 10.3390/md19010039.
7. Martins D., et al. “Hotheaded”: the role OF TRPV1 in brain functions. Neuropharmacology. 2014;85:151– 157. DOI: 10.1016/j.neuropharm.2014.05.034.
8. McEwen B.S. Neurobiological and Systemic Effects of Chronic Stress. Chronic stress (Thousand Oaks, Calif.). 2017;1:2470547017692328. DOI: 10.1177/2470547017692328.
9. Mental disorders. World Health Organization, 2022.
10. Pavlov V.M., et al. The Study of TRPV1 Channels of the Central Nervous System and Their Effect on Anxiety in ICR Mice. Dokl. Biochemistry and Biophysics. 2024;518(1):372–375. DOI: 10.1134/S1607672924600325.
Review
For citations:
Pavlov V.M., Fedotova A.Yu., Andreev Ya.A., Dyachenko I.A. Effect of TRPV1 Channel Inhibitor on Physiological Parameters of ICR Mice under Chronic Stress. Journal Biomed. 2025;21(4):138-142. (In Russ.) https://doi.org/10.33647/2074-5982-21-4-138-142
JATS XML



























